PsiOxus Therapeutics

PsiOxus Therapeutics aims to be the world’s leading cancer gene therapy company, delivering medicines of value to patients with cancer. Our work is product and platform based with a focus on discovering and developing gene-based immuno-oncology therapies for the treatment of solid tumors. The company is headquartered in Abingdon, Oxfordshire, United Kingdom.